Further characterization of α2/α3-selective GABAA receptor positive allosteric modulators as novel analgesics
My research is focused on characterizing compounds that act on specific subunits of GABAA receptors, and evaluating how effective they are at relieving chronic pain and reducing side effects of opioid analgesics (such as tolerance and opioid-induced hyperalgesia) in combination therapies.